Literature DB >> 21432108

SST-2 tumor inoculation is a useful model for studying the anti-tumor immune response in SHR rats.

Naomi Nishio1, Katsutaka Oishi, Kazuhiko Machida.   

Abstract

OBJECTIVE: The purpose of the present study was to investigate the relation between the dose of tumor cell inoculation (especially the doses less than minimum required to evoke tumor growth) and the anti-tumor immune system, particularly lymphoblast formation and cytotoxic activity of lymphcytes.
METHOD: We inoculated rats with various doses of SST-2 tumor cells and examined natural killer (NK) cell activity and lymphoblast formationin vitro. RESULT: The results showed that the cytotoxicities against SST-2 cells and lymphoblast formation of lymphocytes were enhanced by small dose inoculation of tumor cells that could not induce tumor growth.
CONCLUSION: It was suggested that was lymphocutes play an important role as an anti-tumor immune system at small doses of tumor inoculation, which appears to reflect an early stage of tumor growthin vivo. It was also suggested that SST-2 tumor inoculation might be a useful model for studying the anti-tumor immune response in SHR rats.

Entities:  

Keywords:  NK cell; SHR rat; SST-2; T cell; tumor inoculation

Year:  2003        PMID: 21432108      PMCID: PMC2723258          DOI: 10.1007/BF02897936

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  14 in total

1.  Corrections to the original lactate dehydrogenase (LDH) release assay for the evaluation of NK cell cytotoxicity.

Authors:  G Konjević; V Jurisić; I Spuzić
Journal:  J Immunol Methods       Date:  1997-01-15       Impact factor: 2.303

2.  Tumor-induced alteration in macrophage accessory cell activity on autoreactive T cells.

Authors:  A D Yurochko; P S Nagarkatti; M Nagarkatti; K D Elgert
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  [Factors influencing depression of natural killer activity and its prevention in esophageal cancer patients].

Authors:  K Zeze; T Saito; M Kobayashi
Journal:  Nihon Geka Gakkai Zasshi       Date:  1989-01

Review 4.  Role of the major histocompatibility complex class I antigens in tumor growth and metastasis.

Authors:  K Tanaka; T Yoshioka; C Bieberich; G Jay
Journal:  Annu Rev Immunol       Date:  1988       Impact factor: 28.527

5.  An enzyme-release assay for natural cytotoxicity.

Authors:  C Korzeniewski; D M Callewaert
Journal:  J Immunol Methods       Date:  1983-11-25       Impact factor: 2.303

6.  Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).

Authors:  S C Wright; B Bonavida
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

7.  Schwannoma cells induce a tumor-cell-specific cytotoxic-T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factors.

Authors:  U Altenschmidt; R Kahl; E Klundt; E Stöcklin; M Mihatsch; K Weindel; B Groner
Journal:  Int J Cancer       Date:  1997-03-04       Impact factor: 7.396

8.  Age-related changes of natural antitumor resistance in spontaneously hypertensive rats with T-cell depression.

Authors:  T Matsuoka; N Takeichi; H Kobayashi
Journal:  Cancer Res       Date:  1987-07-01       Impact factor: 12.701

9.  Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma.

Authors:  N Kawarabayashi; S Seki; K Hatsuse; T Ohkawa; Y Koike; T Aihara; Y Habu; R Nakagawa; K Ami; H Hiraide; H Mochizuki
Journal:  Hepatology       Date:  2000-11       Impact factor: 17.425

10.  A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Authors:  C Traversari; P van der Bruggen; I F Luescher; C Lurquin; P Chomez; A Van Pel; E De Plaen; A Amar-Costesec; T Boon
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  1 in total

1.  Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model.

Authors:  Jennifer S Dickey; Yanira Gonzalez; Baikuntha Aryal; Steven Mog; Asako J Nakamura; Christophe E Redon; Ulrich Baxa; Elliot Rosen; Gang Cheng; Jacek Zielonka; Palak Parekh; Karen P Mason; Joy Joseph; Balaraman Kalyanaraman; William Bonner; Eugene Herman; Emily Shacter; V Ashutosh Rao
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.